Weekend Read: Europe’s €29bn Pet Food Market Defies the Cost of Living

0
5

07 November 2026 — EBM Weekend Read — By Nick Staunton

Europeans have spent the past three years cutting back. Food, energy and mortgages have all cost more, and eurozone inflation is back at 4%. Yet one budget has barely flinched. Europe now has 306 million pets living in 140 million homes, almost half of all households, according to the industry body FEDIAF. Its members produced €29.4bn of pet food in 2024.

Behind those figures sits one of Europe’s most dependable businesses. It runs from the bowl to the operating table, and in the past decade it has attracted some of the world’s biggest investors. The question now is whether owners’ loyalty is being turned into pricing power.

Join The European Business Briefing

New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.

Subscribe

Paying More, Not Buying More

The detail in FEDIAF’s figures is more telling than the total. Pet food volumes rose by just 1% in 2024, while the value of sales rose 4%. Europeans are not buying much more food for their animals. They are paying more for it.

Part of that is inflation. Part of it is that owners keep trading up to premium, specialist and veterinary diets, even when they are trimming their own shopping. A family may switch to a cheaper supermarket brand of pasta, but few want to be seen doing the same to the dog. That makes pet care rare in consumer goods: a market where price rises do not seem to drive customers away.

Investors understand this well. The same logic has driven deals across leisure and lifestyle brands, from LVMH’s Hyrox move to the wider hunt for businesses with loyal customers and steady cash.

The Vet Is the Real Prize

Pet food is a large market, but the vet clinic is where the money has gone. Mars, best known for chocolate, now runs a pet business of about $30bn under its new global president, Marc Carena. Alongside Royal Canin, Pedigree and Whiskas, it owns veterinary groups including AniCura and Linnaeus.

Private equity has moved even faster. IVC Evidensia, owned by EQT, Silver Lake and Nestlé, has more than 2,300 clinics in 19 countries, making it Europe’s largest vet group. KKR, JAB and CVC all have stakes in the sector.

The model is simple. Buy independent practices, share costs and systems, and raise revenue per visit. It has also been funded heavily with debt. In early 2025, IVC Evidensia’s borrowings stood at more than seven times its earnings, according to S&P. That was manageable when money was cheap. With the Federal Reserve raising rates again and the wider bond sell-off, it is less comfortable. Investors in private credit, who lend to many such deals, are already nervous.

Britain Shows Where This Leads

The UK offers a preview of a consolidated market. Six large groups own more than 60% of British practices, and in March the Competition and Markets Authority concluded its investigation, calling it the most extensive review of veterinary services in a generation.

Its findings were stark. Vet prices rose 63% between 2016 and 2023, almost double general inflation. The large groups charged on average 18.3% more than independents, and fewer than half of their customers knew their local practice belonged to a chain.

The remedies are significant. Written prescription fees will be capped at £21 for the first medicine, compared with the £30 or more many practices charged. Practices must publish price lists, give written estimates for larger treatments and show clearly who owns them. The CMA says owners buying long-term medication online could save £200 a year or more.

Continental Europe is at an earlier stage. In Germany, corporate groups ran fewer than 5% of practices in 2024, although they tend to own the larger, more profitable clinics. That gap is the opportunity investors see. It is also the warning regulators should take from Britain.

The Next Squeeze

There are other pressures. Pet food is a meat-heavy product, and as companies face growing pressure to report their environmental impact, its footprint will draw more attention. Carbon accounting is spreading through supply chains, and Europe’s waste economy offers the industry obvious routes, from by-products to recycled packaging.

Staffing is another strain. Fewer young vets want to own their own practice, which is one reason so many owners have sold to the groups. The corporate model solves a succession problem, but it also makes the industry more dependent on a few large employers.

The Call

Pet care deserves its reputation as one of Europe’s most resilient consumer businesses. Owners treat their animals as family, and they pay accordingly. But that loyalty has limits. Britain’s experience shows what happens when consolidation runs ahead of competition: prices rise faster than inflation, customers do not know who owns their vet, and regulators step in. Investors buying up Europe’s clinics would be wise to learn from that before Brussels and national regulators do it for them. The pet economy is recession-proof. It is not regulation-proof.

Related Analysis

Previous articleWeekend Read- Who Really Owns Every Duty-Free Shop in Europe?
Nick Staunton
Nick Staunton is the Editor and Chief Executive of European Business Magazine, one of Europe's leading business and geopolitical analysis publications. He writes primarily on European markets, fintech, defence industry consolidation, and the business impact of geopolitical events. Nick has over a decade of experience in digital publishing and holds editorial responsibility for EBM's coverage of European rearmament, the Iran war's economic consequences, and the structural shifts reshaping European capital markets. He is based in the United Kingdom and is also Chief Executive of NST Publishing Ltd, the parent company of European Business Magazine

LEAVE A REPLY

Please enter your comment!
Please enter your name here